Can a smartphone app beat cervical cancer in rural kenya?
NCT ID NCT05848557
First seen Jun 24, 2026 · Last updated Aug 14, 2026 · Updated 4 times
Summary
This study is testing a mobile app called mSaada that helps community health workers educate women, track screening, and send reminders for cervical cancer screening. The trial involves 6,000 women and health workers across 12 health facilities in western Kenya. The goal is to see if the app increases screening rates, treatment follow-up, and knowledge about cervical cancer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- mSaada mobile health application
- What this could lead to
- If successful, this could show that a simple mobile app can significantly boost cervical cancer screening rates and follow-up care in low-resource settings.
- What could go wrong
- This is a pilot and early-stage trial focused on feasibility and usability, not yet on clinical outcomes. The app may not work as well in real-world conditions or may not be adopted widely.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kenya Medical Research Institute
RECRUITINGKisumu, Kisumu County, Kenya
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug shrink Hard-to-Treat gynecological tumors?
- Can Long-Term tucatinib use remain safe for HER2-Positive cancers?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Can an antiviral make radiation more effective against cervical cancer?
- A One-Two punch against cervical cancer: testing plus vaccination in HIV-Positive women
- Could Self-Sampling revolutionize cervical cancer screening?